Clinical Trial Update: C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Bem/RZR versus Sofosbuvir/Velpatasvir for chronic hepatitis C is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• BEM/RZR
• SOF/VEL (Sofosbuvir/Velpatasvir)

Snippet

Sponsor: Atea Pharmaceuticals, Inc. | Conditions: HEPATITIS C VIRUS CHRONIC INFECTION, Hepatitis C, Chronic | Phase 3 | Status: RECRUITING